|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2007-2-15
|
|
pubmed:abstractText |
To investigate the utility of a week-4 virological response for sustained response prediction in hepatitis C virus (HCV) genotype 3/HIV-co-infected patients treated with interferon and ribavirin for 24 weeks.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0269-9370
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
19
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
477-81
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:17301566-Adult,
pubmed-meshheading:17301566-Antiviral Agents,
pubmed-meshheading:17301566-Drug Administration Schedule,
pubmed-meshheading:17301566-Drug Monitoring,
pubmed-meshheading:17301566-Drug Therapy, Combination,
pubmed-meshheading:17301566-Female,
pubmed-meshheading:17301566-Genotype,
pubmed-meshheading:17301566-HIV Infections,
pubmed-meshheading:17301566-Hepacivirus,
pubmed-meshheading:17301566-Hepatitis C, Chronic,
pubmed-meshheading:17301566-Humans,
pubmed-meshheading:17301566-Interferon-alpha,
pubmed-meshheading:17301566-Male,
pubmed-meshheading:17301566-Polyethylene Glycols,
pubmed-meshheading:17301566-RNA, Viral,
pubmed-meshheading:17301566-Recombinant Proteins,
pubmed-meshheading:17301566-Recurrence,
pubmed-meshheading:17301566-Retrospective Studies,
pubmed-meshheading:17301566-Ribavirin,
pubmed-meshheading:17301566-Treatment Outcome,
pubmed-meshheading:17301566-Viral Load
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Utility of week-4 viral response to tailor treatment duration in hepatitis C virus genotype 3/HIV co-infected patients.
|
|
pubmed:affiliation |
Infectious Diseases Department, Spain. mcrespo@vhebron.net
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
